GN Store Nord | GN - Ebitda

Aktienkurs
96.50
Täglich Wechseln
4.60 5.01%
Monatlich
3.32%
Jährlich
-17.66%
Q1 Prognose
82.40




Ebitda Veränderung Datum
Demant DKK 2.76B 165M 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Genmab DKK 186M 291M 2025-12
Getinge SEK 3.47B 2.13B 2024-12
GN Store Nord DKK 627M 106M 2025-12
Lonza CHF 1.01B 54M 2025-12
Pandora DKK 4.79B 3.27B 2025-12
Philips EUR 738M 9M 2025-09
Smith & Nephew USD 796M 139M 2025-12
Trinity Biotech USD -9.6M 7.64M 2024-12